Doctolib runs a digital healthcare platform that connects patients with healthcare professionals, mainly in France, Germany, and Italy. It provides online appointment booking, teleconsultation, and practice-management tools through subscription-based software for medical practices, hospitals, and individual clinicians. The platform helps patients find and book care quickly while giving providers a centralized system to manage schedules, patient communications, and administrative tasks. Unlike many options that focus on one feature, Doctolib combines patient access with practice management in a single solution, serving multiple types of healthcare clients across several European countries. The company’s goal is to make healthcare more efficient and easier to access by streamlining operations for providers and reducing barriers to care for patients, using a scalable subscription model to grow across markets.
Company Size
1,001-5,000
Company Stage
Late Stage VC
Total Funding
$810.9M
Headquarters
Levallois-Perret, France
Founded
2013
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Nvidia stock in focus: AI group invests in doctors' platform Doctolib. Oct 13, 2026, 10:19 p.m. US chipmaker Nvidia is taking a minority stake in the French doctors' platform Doctolib. Doctolib CEO Stanislas Niox-Chateau announced this in Paris in the evening. "This investment will enable us to attract AI talent more quickly and drive our development forward," he stressed. It initially remained unclear how many shares Nvidia would acquire. With Nvidia's investment, Doctolib aims to further develop its own artificial intelligence-based solutions and models in Europe, the company announced. In Germany, Doctolib is known primarily for its online platform through which patients can book appointments with medical practices. Another core product is the AI telephone assistant, which medical practices can also use to organize appointments by phone. The company also offers solutions for administrative and accounting tasks in practices. Doctolib builds its own applications on existing language models. With Nvidia's investment, the company says it hopes to gain access to the US group's AI experts and support in training its own models. Nvidia chips: central engine of the AI boom Nvidia, in turn, is the central engine of the AI boom with its chip products for data centers. Above all, cloud heavyweights such as Amazon, Google, Microsoft, and Meta are investing hundreds of billions of dollars in expanding AI data centers. Most recently, Nvidia strengthened its position with a multibillion-dollar acquisition of the AI platform Hugging Face. The group often uses the billions in profits from its chip sales for investments - usually in companies that are customers of the group. Doctolib emphasized that all of the company's health data were stored on servers within the European Union and the United Kingdom and remained there. "This also applies to the AI models," it said. The Nvidia stock ultimately traded 0.27 percent higher at $229.15 in Nasdaq trading. /maa/DP/men Berlin (dpa-AFX) Selected leveraged products on Amazon. With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the desired leverage and we will show you suitable open-end products on Amazon. | Name | Leverage | Knock-out | Issuer | | Mini Future Long on Amazon | 5.00 | 218.10 | Morgan Stanley | | Turbo Long on Amazon | 4.98 | 207.42 | Morgan Stanley | | Turbo Long on Amazon | 4.98 | 207.50 | Morgan Stanley | | Turbo Long on Amazon | 4.95 | 207.64 | Morgan Stanley | | Mini Future Long on Amazon | 4.95 | 217.58 | Morgan Stanley | You can obtain the base prospectus as well as the final terms and the key information documents here: MN756X, MR2GNC, MR85QR, MN7NQ3, MN756W. Please also note the further information** on this advertisement. Risk warning: On average, 7 out of 10 retail investors suffer losses when trading turbo certificates. Turbo certificates are highly risky products and are not suitable for long-term investment strategies.
Nvidia will buy a minority stake in French healthcare booking platform Doctolib. Doctolib did not specify the size or value of the stake. It said Nvidia's presence would help it develop artificial intelligence tools.
TECH | Doctolib gets a foothold in the United Kingdom. Published on May 7, 2026 at 4:02 PM, updated on May 7, 2026 at 4:03 PM | 589 words The unicorn Doctolib takes a foothold across the Channel with the acquisition... After the acquisition of Italian Dottori.it in 2021, Dutch Siilo in 2023 and German Aaron.ai in 2024, the French unicorn Doctolib is setting up in the United Kingdom with the acquisition of Medicus (...) To access this article, the entire site and our databases, discover our subscription plans. BioTech, FinTech, MedTech... Follow all the deals and movements of TECH on social networks.
The French scaleup says plans to hire 150 people and open a R&D centre in London
Doctolib, AP-HP and Roche have launched Care Forward, a support programme for European healthtech startups at STATION F in Paris. The initiative aims to bridge the gap between healthcare innovation and clinical deployment by providing startups with direct access to hospital environments, regulatory expertise and AI support. The programme targets startups developing technologies across the care pathway, including digital solutions, AI, connected devices and healthcare services. Doctolib will offer technology integration and European deployment strategies, whilst AP-HP provides access to clinical environments across Europe's largest university hospital system with 38 hospitals. Roche will assist with regulatory navigation and health economic validation. Participating startups will also gain access to specialised investors and exclusive industry events. Applications are open until 15 May.